Hisamitsu Pharmaceutical Co has a quick ratio of 3.28. It generally indicates good short-term financial strength.
The historical rank and industry rank for Hisamitsu Pharmaceutical Co's Quick Ratio or its related term are showing as below:
FSE:4530'
s Quick Ratio Range Over the Past 10 Years
Min: 3.57 Med: 4.74 Max: 5.97
Current: 3.57
During the past 13 years, Hisamitsu Pharmaceutical Co's highest Quick Ratio was 5.97. The lowest was 3.57. And the median was 4.74.
FSE:4530's Quick Ratio is ranked better than 81.14% of 997
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs FSE:4530: 3.57
Hisamitsu Pharmaceutical Co (FSE:4530) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Hisamitsu Pharmaceutical Co Quick Ratio Related Terms
Hisamitsu Pharmaceutical Co Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hisamitsu Pharmaceutical Co Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Hisamitsu Pharmaceutical Co's Quick Ratio falls into.
Hisamitsu Pharmaceutical Co Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hisamitsu Pharmaceutical Co (FSE:4530) has a Quick Ratio of 3.28 as of Nov. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Hisamitsu Pharmaceutical Co and its competitors. This is 31% below median its historical median of 4.74. Over the past decade, Hisamitsu Pharmaceutical Co's Quick Ratio has ranged from 3.57 to 5.97. According to the industry distribution chart, Hisamitsu Pharmaceutical Co ranks #188 out of 997 companies in the Drug Manufacturers industry, placing it in the top 18.9%.
Is Hisamitsu Pharmaceutical Co's Quick Ratio too high?
Hisamitsu Pharmaceutical Co's current Quick Ratio of 3.28 is 31% below median its 10-year median of 4.74. Over the past 10 years, this metric has ranged from a low of 3.57 to a high of 5.97. The Drug Manufacturers industry median Quick Ratio is 1.45. Hisamitsu Pharmaceutical Co's value of 3.28 is 126.2% above this industry median. Based on the distribution chart, Hisamitsu Pharmaceutical Co ranks #188 out of 997 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Hisamitsu Pharmaceutical Co has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Hisamitsu Pharmaceutical Co's Quick Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Hisamitsu Pharmaceutical Co ranks #188 out of 997 companies for Quick Ratio. This places Hisamitsu Pharmaceutical Co in the top 19% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.45. Hisamitsu Pharmaceutical Co's value of 3.28 is 126.2% above this benchmark. Historically, Hisamitsu Pharmaceutical Co's own Quick Ratio has ranged from 3.57 to 5.97 over the past decade. While the company's 10-year median is 4.74 vs. the industry median of 1.45, Hisamitsu Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 997 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hisamitsu Pharmaceutical Co's current Quick Ratio of 3.28 is 126.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Hisamitsu Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hisamitsu Pharmaceutical Co's current Quick Ratio is 3.28, which is 31% below median its own 10-year median of 4.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hisamitsu Pharmaceutical Co stock overvalued right now?
Hisamitsu Pharmaceutical Co (FSE:4530) has a current Quick Ratio of 3.28. The stock's GF Value™ is 円3,237.07, compared to a current price of 円3,975.00 — trading 22.8% above its estimated fair value. The current Quick Ratio is 3.28, which is 31% below median its 10-year median of 4.74 and 126.2% above the Drug Manufacturers industry median of 1.45. Hisamitsu Pharmaceutical Co's overall GF Score™ is 89/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Hisamitsu Pharmaceutical Co (FSE:4530), the current Quick Ratio is 3.28 as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hisamitsu Pharmaceutical Co (FSE:4530) Overvalued in 2026?
Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co stock appears to be overvalued.
The current stock price of 円3,975.00 is trading 22.8% above its estimated GF Value™ of 円3,237.07.
Key valuation signals for FSE:4530:
Quick Ratio: 3.28 (31% below median its 10-year median of 4.74)
GF Value™: 円3,237.07 vs. price of 円3,975.00 (22.8% above fair value)
Industry Position: 126.2% above the Drug Manufacturers median (#188 of 997)
No single metric tells the full story. See the FSE:4530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
89GF Score
Get the complete analysis for FSE:4530
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FSE:4530 has been successfully added to your 
